BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

FDA Device Recall #Z-2067-2026 - Class II, April 22, 2026

Recall Summary

Recall Number Z-2067-2026
Classification Class II - Moderate risk
Date Initiated April 22, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm BioFire Diagnostics, LLC
Location Salt Lake City, UT
Product Type Devices
Quantity 106 kits (3,180 test)

Product Description

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Reason for Recall

Contamination to in-vitro diagnostic test may result in false positives.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia.

Lot / Code Information

Lot #s:0883425,0878825/DI: 00815381020192

Other Recalls from BioFire Diagnostics, LLC

Recall # Classification Product Date
Z-2936-2026 Class II BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 42374... Jun 24, 2026
Z-2081-2026 Class II Biofire Spotfire Respiratory/Sore Throat Panel ... Apr 1, 2026
Z-0602-2026 Class II BioFire Respiratory Panel 2.1, IVD, REF: 423742... Oct 22, 2025
Z-1877-2025 Class II BioFire Respiratory Panel 2.1 plus Kit, REF: 42... Apr 30, 2025
Z-1518-2025 Class II FilmArra Pneumonia Panel plus (Pneumoplus), REF... Feb 27, 2025

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately, you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.